What Is the Role of Rituximab in Nodular Lymphocyte-Predominant Hodgkin Lymphoma?

被引：0
|
作者：
Eichenauer, Dennis A. [1 ]
Engert, Andreas
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, DE-50937 Cologne, Germany
来源：
ACTA HAEMATOLOGICA | 2015年 / 134卷 / 03期
关键词：
STUDY-GROUP GHSG; PHASE-2;
D O I：
10.1159/000381765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 186
页数：2
相关论文
共 50 条
  • [21] Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Advani, Ranjana H.
    Horning, Sandra J.
    Hoppe, Richard T.
    Daadi, Sarah
    Allen, John
    Natkunam, Yasodha
    Bartlett, Nancy L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) : 912 - +
  • [22] Current treatment options for nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Engert, Andreas
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (05) : 395 - 399
  • [23] Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
    Al-Mansour, Mubarak
    Connors, Joseph M.
    Gascoyne, Randy D.
    Skinnider, Brian
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 793 - 799
  • [24] Individualized patient care in nodular lymphocyte-predominant Hodgkin lymphoma
    Borchmann, Sven
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2022, (01) : 717 - 722
  • [25] International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Binkley, Michael Sargent
    Flerlage, Jamie E.
    Savage, Kerry J.
    Akhtar, Saad
    Steiner, Raphael
    Zhang, Xiao-Yin
    Dickinson, Michael
    Prica, Anca
    Major, Ajay
    Hendrickson, Peter G.
    Hopkins, David
    Ng, Andrea
    Casulo, Carla
    Baron, Jonathan
    Roberts, Kenneth B.
    Al Kendi, Jalila
    Balogh, Alex
    Ricardi, Umberto
    Torka, Pallawi
    Specht, Lena
    De Silva, Ravindu
    Pickard, Keir
    Blazin, Lindsay J.
    Henry, Michael
    Smith, Christine M.
    Halperin, Daniel
    Brady, Jessica
    Brennan, Bernadette
    Senchenko, Maria Anatolevna
    Reeves, Marie
    Hoppe, Bradford S.
    Terezakis, Stephanie
    Talaulikar, Dipti
    Picardi, Marco
    Kirova, Youlia
    Fergusson, Paige
    Hawkes, Eliza A.
    Lee, Denise
    Doo, Nicole Wong
    Barraclough, Allison
    Cheah, Chan Y.
    Ku, Matthew
    Hamad, Nada
    Mutsando, Howard
    Gilbertson, Michael
    Marconi, Tamara
    Viiala, Nicholas
    Maurer, Matthew J.
    Eichenauer, Dennis A.
    Hoppe, Richard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (19) : 2271 - 2280
  • [26] Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses
    Hartmann, S.
    Cogliatti, S.
    Hansmann, M. -L.
    PATHOLOGE, 2013, 34 (03): : 233 - 243
  • [27] Identifying Racial Differences in Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Flowers, Christopher R.
    Nastoupil, Loretta J.
    CANCER, 2015, 121 (19) : 3387 - 3389
  • [28] Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma
    A Stamatoullas
    J-M Picquenot
    C Dumesnil
    P Ruminy
    D Penther
    P Bertrand
    M-N Courel
    C Maisonneuve
    A François
    P Gaulard
    H Tilly
    C Bastard
    Leukemia, 2007, 21 : 2064 - 2067
  • [29] Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma
    Spinner, Michael A.
    Varma, Gaurav
    Advani, Ranjana H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (01) : 17 - 29
  • [30] Bone marrow involvement by nodular lymphocyte-predominant Hodgkin lymphoma
    Parsons, Katrina E.
    Goodlad, John R.
    Leach, Mike
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (03) : 394 - 394
12345